Literature DB >> 11035732

Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.

T F Murphy1, A L Brauer, N Yuskiw, T J Hiltke.   

Abstract

Outer membrane protein E (OMP E) is a 50-kDa protein of Moraxella catarrhalis which possesses several characteristics indicating that the protein will be an effective vaccine antigen. To study the antigenic structure of OMP E, eight monoclonal antibodies were developed and characterized. Three of the antibodies recognized epitopes which are present on the bacterial surface. Fusion peptides corresponding to overlapping regions of OMP E were constructed, and immunoblot assays were performed to localize the areas of the molecule bound by the monoclonal antibodies. These studies identified a surface-exposed epitope in the region of amino acids 80 through 180. To further study the protein, two mutants which lack OMP E were constructed. In bactericidal assays, the mutants were more readily killed by normal human serum compared to the isogenic parent strains. These results indicate that OMP E is involved in the expression of serum resistance of M. catarrhalis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035732      PMCID: PMC97706          DOI: 10.1128/IAI.68.11.6250-6256.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR.

Authors:  A Urban; S Neukirchen; K E Jaeger
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

2.  Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.

Authors:  R Bhushan; C Kirkham; S Sethi; T F Murphy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 3.  Otitis media: etiology and diagnosis.

Authors:  O Ruuskanen; T Heikkinen
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

Review 4.  Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.

Authors:  M C Enright; H McKenzie
Journal:  J Med Microbiol       Date:  1997-05       Impact factor: 2.472

5.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 6.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

7.  Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis.

Authors:  R Bhushan; R Craigie; T F Murphy
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.

Authors:  M E Helminen; I Maciver; M Paris; J L Latimer; S L Lumbley; L D Cope; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

Review 9.  Otitis media.

Authors:  J O Klein
Journal:  Clin Infect Dis       Date:  1994-11       Impact factor: 9.079

10.  Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis.

Authors:  K L Klingman; A Pye; T F Murphy; S L Hill
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

View more
  16 in total

1.  Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Authors:  John P Hays; Saskia van Selm; Theo Hoogenboezem; Silvia Estevão; Kimberly Eadie; Peter van Veelen; Jan Tommassen; Alex van Belkum; Peter W M Hermans
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.

Authors:  Daxin Peng; Biswa P Choudhury; Ronald S Petralia; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 7.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

8.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.

Authors:  Melanie M Pearson; Eric R Lafontaine; Nikki J Wagner; Joseph W St Geme; Eric J Hansen
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression.

Authors:  Wei Wang; Larry Reitzer; David A Rasko; Melanie M Pearson; Robert J Blick; Cassie Laurence; Eric J Hansen
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.